Bristol-myers Squibb Company

États‑Unis d’Amérique


 
Quantité totale PI 4 890
Quantité totale incluant filiales 5 460 (+ 575 pour les filiales)
Rang # Quantité totale PI 221
Note d'activité PI 4/5.0    2 215
Rang # Activité PI 304
Activité incl filiales 3,7/5.0    2 263
Symbole boursier
ISIN US1101221083
Capitalisation 119,099M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 070 290
260 292
1 654 0
324
 
Dernier brevet 2025 - Substituted oxoisoindolinyl pipe...
Premier brevet 1975 - Cephalosporin esters
Dernière marque 2025 - BYMCLIXIO
Première marque 1951 - LOWILA

Filiales

29 subsidiaries with IP (537 patents, 38 trademarks)

84 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metab...
P/S Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases,...
2024 P/S Pharmaceutical and biological preparations for human use.
Invention Aminotriazolopyridines as kinase inhibitors. Compounds having formula (I)-(IX), and enantiomers,...
Invention Framework for document layout and information extraction. A method includes receiving a file in ...
Invention Crystalline forms of a par4 inhibitor. The present invention relates to co-crystals of the compo...
Invention Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-mor...
Invention Substituted oxoisoindolinyl piperidine-2,6-dione compounds. Disclosed are compounds of Formula (...
Invention Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonists. The present invention provides ...
Invention Substituted phenyl oxooxazolyl piperidine dione compounds. Disclosed are compounds of Formula (I)...
Invention Serially-connectable drug modules for combinatorial drug delivery device. A combinatorial drug d...
Invention Methods of treating tumor. The disclosure provides a method for treating a subject afflicted wit...
Invention Triazolopyridinyl compounds as kinase inhibitors. Compounds having formula (I), and enantiomers,...
Invention Co-crystals of nitroxyl donating compounds. NN-hydroxysulfonamide compounds, pharmaceutical compo...
Invention Compositions comprising antibodies that bind bcma and cd3 and methods of treatment. Provided here...
Invention Ceramic hydroxyapatite chromatography flow through method. The present disclosure is directed met...
Invention Substituted pyridopyrimidinonyl compounds useful as t cell activators. Disclosed are compounds o...
Invention Assay to determine in vivo receptor occupancy. The present invention relates to assays for monit...
Invention Methods of treating colorectal cancer. This disclosure provides methods for treating a tumor der...
Invention Methods of assessing citrullination and activity of pad4 modulators. The present application rela...
Invention Heterocyclic pad4 inhibitors. The disclosure generally relates to compounds of Formula I, which a...
Invention Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer age...
Invention Kras inhibitors. The present disclosure provides KRAS inhibitors. Methods of treating cancers usi...
Invention Lag-3 antagonist therapy for lung cancer. The disclosure provides a method of treating a human s...
Invention Substituted oxoisoindolinyl piperidine-2,6-dione compound as anticancer agent. Disclosed is a com...
Invention Lag-3 combination therapy for the treatment of cancer. The invention provides a method of treati...
Invention Treatment of lag-3 positive tumors. The invention provides a method of treating a tumor in a hum...
Invention Near real time sialic acid quantitation of glycoproteins. Systems and methods for the automatic q...
Invention Biomarkers and methods of treatment of follicular lymphoma. Provided herein are methods and kits ...
Invention Spirocyclic substituted oxoisoindolinyl piperidine-2,6-dione compound. Disclosed is a compound of...
Invention Radioligands for imaging the lpa1 receptor. The present invention relates to radiolabeled LPA1 r...
Invention Substituted oxazolone compound for decreasing levels of ikzf1-4 proteins. Disclosed is a compound...
Invention Ionizable lipids. The application relates to ionizable lipids. The formulations of ionizable lip...
Invention Ionizable lipids. The application relates to ionizable lipids. The formulations of ionizable lipi...
Invention H- pyrido[3,2-2β]indole-7-methanol. HSHHbb]indole-7-methanol. Characterization data for the cryst...
Invention Cancer immunotherapy by disrupting pd-1/pd-l1 signaling. The disclosure provides a method for im...
Invention Antibodies against il-7r alpha subunit and uses thereof. Provided herein are antibodies that bin...
2022 Invention Systems and methods of selecting compounds that induce conformational changes in mutant cereblon....
Invention Detergent for viral inactivation. The present disclosure provides compositions and methods of in...
Invention Benzothiazole, benzoisoxazole, and benzodioxole analogs as rxfp1 receptor agonists. The disclosu...
Invention Bicyclo [3.2.0] heptane bis(amide) rxfp1 agonists. The disclosure relates to compounds of Formul...
Invention Rxfp1 agonists. The disclosure relates to compounds of Formula (I), which arm RXFP1 receptor ago...
Invention Rxfp1 agonists. The disclosure relates to compounds of Formula (I), which are RXFP1 receptor ago...
Invention Lag-3 antagonist therapy for hematological cancer. The disclosure provides a method of treating ...
Invention Methods for determining responsiveness to tyk2 inhibitors. Disclosed are methods of treating pso...
Invention Methods of treating hair-loss disorders with tyk2 inhibitors. Methods of preventing or treating ...
Invention Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant ...
Invention Compound useful for pet-imaging of bruton’s tyrosine kinase. Disclosed is a compound of Formula ...
Invention Tricyclic fused pyrimidine compounds for use as her2 inhibitors. Provided herein are tricyclic f...
Invention Macrocyclic immunomodulators. In accordance with the present disclosure, macrocyclic compounds h...
Invention Drug cartridge, drug delivery device, and methods for preparing thereof. In one aspect, a drug d...
Invention Substituted heterocyclic compounds. There are disclosed compounds of the following formula (I): ...